| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $2.33 (Beat by $0.13) |
| EPS GAAP Actual | $2.33 (Beat by $0.13) |
| Revenue Actual | $0.728B |
| Revenue Surprise | Beat by $728M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.68 |
| EPS GAAP Estimate | $1.68 |
| Revenue Estimate | $0.814B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2030 | 14.4 | 25.59 | 13.47826 | 15.57126 | 1 |
| Jun 2029 | 11.05 | 33.35 | 10.28361 | 11.81806 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.1 | 0.7 | 0.728B | 7.02% | -43M |
| FQ3 2025 (Sep 2025) | 2.45 | 1.05 | 0.7337B | 2.19% | -37.3M |
| FQ2 2025 (Jun 2025) | 2.23 | 2.23 | 0.7556B | -5.7% | 755.6M |
| FQ1 2025 (Mar 2025) | 1.9 | 1.9 | 0.727B | 5.79% | 727M |
| FQ4 2024 (Dec 2024) | 1.68 | 1.68 | 0.6769B | 7.79% | 676.9M |
| FQ3 2024 (Sep 2024) | 1.69 | 1.69 | 0.7176B | 9.16% | 717.6M |
| FQ2 2024 (Jun 2024) | 1.87 | 1.87 | 0.7987B | 5.08% | 798.7M |
| FQ1 2024 (Mar 2024) | 0.13 | 0.13 | 0.6849B | -0.76% | 684.9M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.68
Consensus Revenue Estimates
0.814B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 3.53131 | -- | 3.41763 | 3.67349 | 1 |
| FQ4 2027 (Dec 2027) | 3.14632 | -- | 3.04504 | 3.273 | 1 |
| FQ3 2027 (Sep 2027) | 3.1154 | -- | 3.01511 | 3.24083 | 1 |
| FQ1 2027 (Mar 2027) | 2.46561 | -- | 2.36875 | 2.55916 | 0 |
| FQ4 2026 (Dec 2026) | 2.43086 | 13.61 | 2.33537 | 2.52309 | 0 |
| FQ3 2026 (Jul 2026) | 1.88 | -30.32 | 1.80337 | 1.9455 | 0 |
| FQ1 2026 (Mar 2026) | 1.68 | -13.1 | 1.55841 | 1.7861 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 0.94B | -- | 0.91B | 0.97B | 1 |
| FQ4 2027 (Dec 2027) | 0.87B | -- | 0.84B | 0.89B | 2 |
| FQ3 2027 (Sep 2027) | 0.86B | -- | 0.84B | 0.89B | 2 |
| FQ1 2027 (Mar 2027) | 0.93B | -- | 0.9B | 0.95B | 1 |
| FQ4 2026 (Dec 2026) | 0.88B | 16.97 | 0.85B | 0.9B | 1 |
| FQ3 2026 (Jul 2026) | 0.86B | 14.39 | 0.83B | 0.88B | 1 |
| FQ1 2026 (Mar 2026) | 0.81B | 10.69 | 0.77B | 0.85B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.4 | 2.1 | 0.7 | 33.33% |
| FQ3 2025 (Sep 2025) | 1.4 | 2.45 | 1.05 | 42.86% |
| FQ2 2025 (Jun 2025) | 2.23 | 2.23 | 100% | |
| FQ1 2025 (Mar 2025) | 1.9 | 1.9 | 100% | |
| FQ4 2024 (Dec 2024) | 1.68 | 1.68 | 100% | |
| FQ3 2024 (Sep 2024) | 1.69 | 1.69 | 100% | |
| FQ2 2024 (Jun 2024) | 1.87 | 1.87 | 100% | |
| FQ1 2024 (Mar 2024) | 0.13 | 0.13 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0.77B | $0.73B | $-43M | -5.91% |
| FQ3 2025 (Sep 2025) | $0.77B | $0.73B | $-37.3M | -5.08% |
| FQ2 2025 (Jun 2025) | $0B | $0.76B | $755.6M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.73B | $727M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.68B | $676.9M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.72B | $717.6M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.8B | $798.7M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.68B | $684.9M | 100% |